Stonepine Capital Management’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$153K Buy
+20,000
New +$196K 0.1% 71

Other funds holding OCUL

Stonepine Capital Management's OCUL Position: Q3 2026 in Review

Stonepine Capital Management opened a new position in Ocular Therapeutix (OCUL) in Q3 2026: 20,000 shares worth $153K. The stake represents 0.1% of the portfolio and ranks #71 among its holdings.

263 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.

  • Stonepine Capital Management held 20,000 shares of Ocular Therapeutix worth $153K as of Q3 2026.
  • Ocular Therapeutix was a new Stonepine Capital Management position in Q3 2026.
  • Ocular Therapeutix made up 0.1% of Stonepine Capital Management's portfolio in Q3 2026, its #71 holding.
  • 263 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.

Based on Stonepine Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.